ジーエヌアイグループの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/06/06 | 2,135 | 2,146 | 2,089 | 2,104 | -19 | -0.9% | 541,800 |
| 2024/06/05 | 2,151 | 2,174 | 2,108 | 2,123 | -39 | -1.8% | 491,600 |
| 2024/06/04 | 2,156 | 2,217 | 2,127 | 2,162 | -12 | -0.6% | 661,700 |
| 2024/06/03 | 2,206 | 2,212 | 2,161 | 2,174 | -29 | -1.3% | 507,200 |
| 2024/05/31 | 2,134 | 2,256 | 2,124 | 2,203 | +86 | +4.1% | 1,297,900 |
| 2024/05/30 | 2,095 | 2,139 | 2,080 | 2,117 | +20 | +1% | 911,900 |
| 2024/05/29 | 2,120 | 2,140 | 2,068 | 2,097 | -3 | -0.1% | 660,200 |
| 2024/05/28 | 2,136 | 2,182 | 2,100 | 2,100 | +14 | +0.7% | 1,048,900 |
| 2024/05/27 | 2,071 | 2,111 | 2,030 | 2,086 | -2 | -0.1% | 854,000 |
| 2024/05/24 | 2,082 | 2,128 | 2,050 | 2,088 | -74 | -3.4% | 925,800 |
| 2024/05/23 | 2,182 | 2,203 | 2,142 | 2,162 | -5 | -0.2% | 588,900 |
| 2024/05/22 | 2,193 | 2,240 | 2,152 | 2,167 | -86 | -3.8% | 1,022,300 |
| 2024/05/21 | 2,317 | 2,344 | 2,235 | 2,253 | -94 | -4% | 1,259,400 |
| 2024/05/20 | 2,128 | 2,383 | 2,122 | 2,347 | +169 | +7.8% | 2,263,800 |
| 2024/05/17 | 2,379 | 2,380 | 2,175 | 2,178 | -245 | -10.1% | 3,416,300 |
| 2024/05/16 | 2,572 | 2,583 | 2,308 | 2,423 | +1 | ±0% | 3,196,500 |
| 2024/05/15 | 2,437 | 2,454 | 2,390 | 2,422 | -30 | -1.2% | 1,511,400 |
| 2024/05/14 | 2,395 | 2,482 | 2,393 | 2,452 | +77 | +3.2% | 911,200 |
| 2024/05/13 | 2,420 | 2,426 | 2,348 | 2,375 | -42 | -1.7% | 759,200 |
| 2024/05/10 | 2,420 | 2,462 | 2,391 | 2,417 | +23 | +1% | 754,600 |
| 2024/05/09 | 2,395 | 2,433 | 2,367 | 2,394 | -6 | -0.3% | 614,800 |
| 2024/05/08 | 2,414 | 2,503 | 2,352 | 2,400 | -14 | -0.6% | 1,288,800 |
| 2024/05/07 | 2,471 | 2,471 | 2,286 | 2,414 | -27 | -1.1% | 1,718,000 |
| 2024/05/02 | 2,406 | 2,530 | 2,401 | 2,441 | +9 | +0.4% | 938,100 |
| 2024/05/01 | 2,451 | 2,464 | 2,394 | 2,432 | -59 | -2.4% | 905,100 |
| 2024/04/30 | 2,556 | 2,577 | 2,490 | 2,491 | -19 | -0.8% | 765,500 |
| 2024/04/26 | 2,484 | 2,514 | 2,437 | 2,510 | +69 | +2.8% | 625,800 |
| 2024/04/25 | 2,461 | 2,468 | 2,422 | 2,441 | -49 | -2% | 504,500 |
| 2024/04/24 | 2,520 | 2,542 | 2,490 | 2,490 | +6 | +0.2% | 410,400 |
| 2024/04/23 | 2,500 | 2,547 | 2,475 | 2,484 | -1 | ±0% | 605,500 |
| 2024/04/22 | 2,458 | 2,500 | 2,414 | 2,485 | +39 | +1.6% | 692,500 |
| 2024/04/19 | 2,566 | 2,572 | 2,348 | 2,446 | -138 | -5.3% | 1,997,300 |
| 2024/04/18 | 2,508 | 2,613 | 2,496 | 2,584 | +50 | +2% | 618,400 |
| 2024/04/17 | 2,613 | 2,620 | 2,497 | 2,534 | -42 | -1.6% | 915,300 |
| 2024/04/16 | 2,600 | 2,634 | 2,566 | 2,576 | -74 | -2.8% | 1,092,900 |
| 2024/04/15 | 2,672 | 2,695 | 2,636 | 2,650 | -83 | -3% | 599,500 |
| 2024/04/12 | 2,774 | 2,830 | 2,718 | 2,733 | +14 | +0.5% | 568,600 |
| 2024/04/11 | 2,820 | 2,826 | 2,696 | 2,719 | -156 | -5.4% | 1,310,100 |
| 2024/04/10 | 2,874 | 2,917 | 2,865 | 2,875 | -12 | -0.4% | 395,900 |
| 2024/04/09 | 2,850 | 2,905 | 2,843 | 2,887 | +28 | +1% | 411,900 |
| 2024/04/08 | 2,919 | 2,919 | 2,837 | 2,859 | -19 | -0.7% | 533,000 |
| 2024/04/05 | 2,928 | 2,934 | 2,862 | 2,878 | -74 | -2.5% | 556,600 |
| 2024/04/04 | 2,890 | 2,984 | 2,861 | 2,952 | +75 | +2.6% | 812,600 |
| 2024/04/03 | 2,834 | 2,919 | 2,813 | 2,877 | +7 | +0.2% | 852,700 |
| 2024/04/02 | 3,005 | 3,015 | 2,870 | 2,870 | -195 | -6.4% | 1,307,300 |
| 2024/04/01 | 3,170 | 3,175 | 3,040 | 3,065 | -45 | -1.4% | 577,900 |
| 2024/03/29 | 3,030 | 3,110 | 2,998 | 3,110 | +105 | +3.5% | 479,100 |
| 2024/03/28 | 3,020 | 3,075 | 3,005 | 3,005 | +20 | +0.7% | 381,800 |
| 2024/03/27 | 3,005 | 3,050 | 2,983 | 2,985 | -6 | -0.2% | 344,900 |
| 2024/03/26 | 3,005 | 3,025 | 2,948 | 2,991 | -44 | -1.4% | 629,100 |
251～
300
件表示中 / 3721件
類似銘柄と比較する
現在ご覧いただいている「ジーエヌアイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ジーエヌアイ | 382,000円 | +21.7% | +999.9% | 0.00% | 16.00倍 | 5.29倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| サワイＧＨＤ | 181,600円 | +5.9% | +684.6% | 3.03% | 12.05倍 | 1.21倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
| キッセイ薬 | 420,000円 | +3.6% | +6.1% | 2.86% | 14.15倍 | 0.83倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| 鳥居薬 | 634,000円 | +7.1% | -35.0% | 0.00% | 52.43倍 | 1.47倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| 科研薬 | 386,700円 | -6.4% | -71.8% | 4.91% | 43.07倍 | 0.96倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
市場注目の銘柄
チャート関連のコラム
